// App-Quantinova.ai

BSH2020‐PO‐111 : Analysis of frontline treatment of non‐transplant elderly myeloma patients in Wales: comparison of bortezomib versus lenalidomide based treatment

Researchers

Presenter

  • C. Bygrave

Principal Investigators

  • F. Hogan

  • E. Mahdi

  • A. Downing

  • A. Simmons

  • T. Burton

  • A. Atkinson

  • A. Goringe

  • H. Jackson

  • J. Murray

  • H. Sati

Medical Centers

  • Rheumatology, University Hospital of Wales, Cardiff, UK

  • Royal Gwent Hospital, Newport, Newport

  • University Hospital of Wales, Cardiff, AK

  • Singleton Hospital Swansea, Swansea

  • Haematology, Royal United Hospital Bath NHS Trust, Bath

  • Haematology, Singleton Hospital, Swansea, Swansea, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • 5'-nucleotidase

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • Active Comparator

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved